K. Peter Öhman

1.4k citations

53 papers · 1.1k indexed · h-index 18

Impact in

Cardiology and Cardiovascular Medicine top 5%
- Blood Pressure and Hypertension Studies
- Renin-Angiotensin System Studies
- Cardiovascular Function and Risk Factors
- Heart Rate Variability and Autonomic Control
Endocrinology, Diabetes and Metabolism top 5%
- Hormonal Regulation and Hypertension

Papers in

Cardiology and Cardiovascular Medicine 36
- Blood Pressure and Hypertension Studies 17
- Renin-Angiotensin System Studies 13
- Heart Rate Variability and Autonomic Control 9
Endocrinology, Diabetes and Metabolism 19
- Hormonal Regulation and Hypertension 13

Co-authors: Fredrik H. Nyström Karin Malmqvist Thomas Kahan Lars Lind Bengt E. Karlberg Håkan Melhus Lisa Kurland Anders Hägg
Journals: Journal of Hypertension (6 papers)Blood Pressure (5 papers)Clinical Cardiology (3 papers)Scandinavian Journal of Clinical and Laboratory Investigation (2 papers)Journal of Cardiovascular Pharmacology (2 papers)
Partner nations: Sweden United States United Kingdom

In The Last Decade

K. Peter Öhman

53 papers receiving 1.1k citations

Peers

Countries citing papers authored by K. Peter Öhman

Since Specialization

Citations

This map shows the geographic impact of K. Peter Öhman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Peter Öhman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Peter Öhman more than expected).

Fields of papers citing papers by K. Peter Öhman

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Peter Öhman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Peter Öhman. The network helps show where K. Peter Öhman may publish in the future.

Co-authors

The 25 scholars most cited alongside K. Peter Öhman, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with K. Peter Öhman Line = papers co-authored together K. Peter Öhman links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	The dual peroxisome proliferator–activated receptor α/γ agonist tesaglitazar further improves the lipid profile in dyslipidemic subjects treated with atorvastatin Metabolism ·Serena Tonstad, Kjetil Retterstøl, Leiv Ose, K. Peter Öhman, Magnus Lindberg, Maria Svensson	2007	12
2	Food Does Not Affect the Pharmacokinetics of Tesaglitazar, a Novel Dual Peroxisome Proliferator‐Activated Receptor α/γ Agonist The Journal of Clinical Pharmacology ·Sven‐Märten Samuelsson, Susanne Johansson, Fahmi Fachri, Djenane Brasil Conceição, K. Peter Öhman	2006	1
3	Transforming growth factor β₁genotype and change in left ventricular mass during antihypertensive treatment–results from the swedish irbesartan left ventricular hypertrophy investigation versus atenolol (Silvhia) Clinical Cardiology ·Pär Hallberg, Lars Lind, Il-Dong Kim, Karl Michaëlsson, Julia Karlsson, Lisa Kurland, Thomas Kahan, Karin Malmqvist, K. Peter Öhman, Fredrik H. Nyström, Ulrika Liljedahl, Ann‐Christine Syvänen, Håkan Melhus	2004	9
4	Beta₁‐adrenergic receptor gene polymorphisms and response to Beta₁‐adrenergic receptor blockade in patients with essential hypertension Clinical Cardiology ·Jacob Karlsson, Lars Lind, Pär Hallberg, Karl Michaëlsson, Lisa Kurland, Thomas Kahan, Karin Malmqvist, K. Peter Öhman, Fredrik H. Nyström, Håkan Melhus	2004	63
5	A single nucleotide polymorphism in the promoter region of the osteoprotegerin gene is related to intima‐media thickness of the carotid artery in hypertensive patients. The Swedish irbesartan left ventricular hypertrophy investigation vs atenolol (SILVHIA) Blood Pressure ·Helena Brändström, Fredrik Stiger, Thomas Kahan, Håkan Melhus, Fredrik H. Nyström, K. Peter Öhman, Karin Malmqvist, Lars Lind, Andreas Kindmark	2004	18
6	B2 bradykinin receptor (B2BKR) polymorphism and change in left ventricular mass in response to antihypertensive treatment Journal of Hypertension ·Pär Hallberg, Lars Lind, Karl Michaëlsson, Julia Karlsson, Lisa Kurland, Thomas Kahan, Karin Malmqvist, K. Peter Öhman, Fredrik H. Nyström, Håkan Melhus	2003	22
7	Nurse-recorded and ambulatory blood pressure predicts treatment-induced reduction of left ventricular hypertrophy equally well in hypertension: results from the Swedish irbesartan left ventricular hypertrophy investigation versus atenolol (SILVHIA) study Journal of Hypertension ·Fredrik H. Nyström, Karin Malmqvist, K. Peter Öhman, Thomas Kahan	2002	10
8	Angiotensin converting enzyme gene polymorphism predicts blood pressure response to angiotensin II receptor type 1 antagonist treatment in hypertensive patients Journal of Hypertension ·Lisa Kurland, Håkan Melhus, Julia Karlsson, Thomas Kahan, Karin Malmqvist, K. Peter Öhman, Fredrik H. Nyström, Anders Hägg, Lars Lind	2001	98
9	Regression of left ventricular hypertrophy in human hypertension with irbesartan Journal of Hypertension ·Karin Malmqvist, Thomas Kahan, Magnus Edner, Claes Held, Anders Hägg, Lars Lind, И.П. Садко, Fredrik H. Nyström, K. Peter Öhman, Mary Osbakken, D. Tilki	2001	142
10	Less Difference between Office and Ambulatory Blood Pressure in Women than in Men Both Before and During Antihypertensive Treatment Blood Pressure ·Fredrik H. Nyström, K. Peter Öhman, Yin Chun-fang, Sean McCann, A Berardi	2000	2
11	Pitfalls in Doppler Evaluation of Diastolic Function: Insights from 3-Dimensional Magnetic Resonance Imaging Journal of the American Society of Echocardiography ·Anna Fyrenius, Lars Wigström, Ann F. Bolger, Tino Ebbers, K. Peter Öhman, Longxian Zhang, Bengt Wranne, Jan Engvall	1999	45
12	Plasma levels of cyclic GMP and endothelin in postmenopausal women with unstable coronary artery disease Scandinavian Journal of Clinical and Laboratory Investigation ·Diondra Penland, Johan Ahlner, Jonas Malmstedt, K. Peter Öhman, Eva Swahn	1999	5
13	A population-based study of the white-coat blood pressure effect: Positive correlation with plasma cortisol Clinical and Experimental Hypertension ·Fredrik H. Nyström, Elisabeth Aardal, K. Peter Öhman	1998	14
14	Effect of Amlodipine Versus Felodipine Extended Release on 24-Hour Ambulatory Blood Pressure in Hypertension American Journal of Hypertension ·Jan Östergren, Yin Chun-fang, Ulf Brodin, 黄小敏, K. Peter Öhman, Rahim Tafazolli	1998	14
15	Circulating Plasma Prekallikrein and Tissue Kallikrein in Normotensive and Hypertensive Humans: Effects of Angiotensin II Infusion Clinical and Experimental Hypertension ·K. Peter Öhman, B. E. Karlberg	1998	1
16	Serum leptin concentrations in a normal population and in GH deficiency: negative correlation with testosterone in men and effects of GH treatment Clinical Endocrinology ·Fredrik H. Nyström, Bertil Ekman, В. В. Логачева, Torbjörn Lindström, K. Peter Öhman, Hans J. Arnqvist	1997	72
17	Twenty‐four hour ambulatory blood pressure in the population Journal of Internal Medicine ·Fredrik H. Nyström, Letícia Hamad de Souza, B. E. Karlberg, K. Peter Öhman	1996	14
18	A Population Study of Plasma Neuropeptide Y: Correlations with Components of the Metabolic Syndrome Blood Pressure ·Fredrik H. Nyström, Peter M. Nilsson, Anders Olsson, Bengt E. Karlberg, K. Peter Öhman	1996	13
19	Thyroid Hormone Restores Atrial Stretch-Induced Secretion of Atrial Natriuretic Peptide in Hypophysectomized Rats Hormone and Metabolic Research ·N. Zamir, Asfaw Kejela, K. Peter Öhman	1993	6
20	Atrial natriuretic factor (ANF 103–126) enhances volume‐ and pressor‐induced heart rate response in the conscious rat Acta Physiologica Scandinavica ·Eric S Marks, K. Peter Öhman, Harry R. Keiser	1990	1

About K. Peter Öhman

K. Peter Öhman is a scholar working on Cardiology and Cardiovascular Medicine, Endocrinology, Diabetes and Metabolism, Complementary and alternative medicine, Genetics and Pharmacology, having authored 53 papers that have together received 1.1k indexed citations. Recurring topics across this work include Blood Pressure and Hypertension Studies (17 papers), Renin-Angiotensin System Studies (13 papers), Hormonal Regulation and Hypertension (13 papers), Heart Rate Variability and Autonomic Control (9 papers), Peroxisome Proliferator-Activated Receptors (7 papers), Coagulation, Bradykinin, Polyphosphates, and Angioedema (6 papers), Cardiovascular and exercise physiology (5 papers) and Nitric Oxide and Endothelin Effects (4 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (622 citations), Endocrinology, Diabetes and Metabolism (399 citations), Pharmacology (138 citations), Endocrine and Autonomic Systems (90 citations) and Biochemistry (48 citations). K. Peter Öhman has collaborated with scholars based in Sweden, United States and United Kingdom. Frequent co-authors include Fredrik H. Nyström, Karin Malmqvist, Thomas Kahan, Lars Lind, Bengt E. Karlberg, Håkan Melhus, Lisa Kurland, Anders Hägg, Julia Karlsson and Pär Hallberg. Their work appears in journals such as Journal of Hypertension, Blood Pressure, Clinical Cardiology, Scandinavian Journal of Clinical and Laboratory Investigation and Journal of Cardiovascular Pharmacology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact